Sarah Alexandrou

Sarah Alexandrou

Garvan Institute of Medical Research - Darlinghurst / Australia
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 4879701
person_outline Sarah Alexandrou's MOST POPULAR ARTICLES
1-) The androgen receptor is a tumor suppressor in estrogen receptor–positive breast cancerTE Hickey, LA Selth, KM Chia, G Laven-Law, HH Milioli, D Roden, ...Nature medicine 27 (2), 310-320, 20211162021
2-) Overcoming CDK4/6 inhibitor resistance in ER-positive breast cancerN Portman, S Alexandrou, E Carson, S Wang, E Lim, CE CaldonEndocrine-related cancer 26 (1), R15-R30, 20191162019
3-) MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancerN Portman, HH Milioli, S Alexandrou, R Coulson, A Yong, KJ Fernandez, ...Breast Cancer Research 22 (1), 1-17, 2020262020
4-) The proliferative and apoptotic landscape of basal-like breast cancerS Alexandrou, SM George, CJ Ormandy, E Lim, SR Oakes, CE CaldonInternational journal of molecular sciences 20 (3), 667, 2019322019
5-) Cyclin E1 and cyclin E2 in ER+ breast cancer: prospects as biomarkers and therapeutic targetsHH Milioli, S Alexandrou, E Lim, CE CaldonEndocrine-related cancer 27 (5), R93-R112, 2020292020